Alexis Norris

Dr. Alexis Norris

FDA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AJAndrew E. Jaffe
Andrew E. Jaffe
RTRan Tao
Ran Tao
ANAlexis Norris
Alexis Norris
MKMarc Kealhofer
Marc Kealhofer
ANAbhinav Nellore
Abhinav Nellore
DWDaniel R. Weinberger
Daniel R. Weinberger
Significance: Many studies use measurements of gene expression in human postmortem and ex vivo tissues like brain and blood to characterize genomic correlates of illness. However, molecular analyses of these tissues can be susceptible to a wide range of confounders that may be difficult to measure and remove. In this article, we describe an analysis framework for identifying and removing previously uncharacterized quality biases in measurements of RNA. Our paper critically highlights the shortcomings of standard RNA quality correction approaches, such as statistically adjusting for RNA integrity numbers. We show that the our framework removes residual confounding by RNA quality and greatly improves replication of significant differentially expressed genes across independent datasets by more than threefold compared with previous approaches.

1 February 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
ANAlexis Norris
Alexis Norris
SLStella S. Lee
Stella S. Lee
KGKevin J. Greenlees
Kevin J. Greenlees
DTDaniel A. Tadesse
Daniel A. Tadesse
MMMayumi F. Miller
Mayumi F. Miller
HLHeather A. Lombardi
Heather A. Lombardi

28 July 2019 in bioRxiv
Verified
Preprint
Open access
ANAlexis Norris
Alexis Norris
SLStella S. Lee
Stella S. Lee
KGKevin J. Greenlees
Kevin J. Greenlees
DTDaniel A. Tadesse
Daniel A. Tadesse
MMMayumi F. Miller
Mayumi F. Miller
HLHeather Lombardi
Heather Lombardi
We analyzed publicly available whole genome sequencing data from cattle which were germline genome-edited to introduce polledness. Our analysis discovered the unintended heterozygous integration of the plasmid and a second copy of the repair template sequence, at the target site. Our finding underscores the importance of employing screening methods suited to reliably detect the unintended integration of plasmids and multiple template copies.

7 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TGTimothy Gilpatrick
Timothy Gilpatrick
JWJosh Zhiyong Wang
Josh Zhiyong Wang
DWDavid Weiss
David Weiss
ANAlexis Norris
Alexis Norris
JEJames R Eshleman
James R Eshleman
WTWinston Timp
Winston Timp
Generating high-coverage sequencing coverage at select genomic loci has extensive applications in both research science and genetic medicine. Long-read sequencing technologies (e.g. nanopore sequencing) have expanded our ability to generate sequencing data in regions (e.g. repetitive elements) that are difficult to interrogate with short-read sequencing methods. In work presented here, we expand on our previous work using CRISPR/Cas9 for targeted nanopore sequencing by using in vitro transcribed guideRNAs, with 1100 guideRNAs in a single experiment. This approach decreases the cost per guideRNA, increases the number of guideRNAs that can be multiplexed in a single experiment, and provides a way to rapidly screen numerous guideRNAs for cutting efficiency. We apply this strategy in multiple patient-derived pancreatic cancer cell lines, demonstrating its ability to unveil structural variation in “deletion hotspots” around the tumor suppressor genes p16 ( CDKN2A ), and SMAD4 .

10 December 2020 in Viruses
Verified
Journal Article
Open access
PDF file
JMJoan Martí-Carreras
Joan Martí-Carreras
AGAlejandro Rafael Gener
Alejandro Rafael Gener
SMSierra D. Miller
Sierra D. Miller
ABAnderson F. Brito
Anderson F. Brito
CCChristiam Camacho
Christiam Camacho
BBBen Busby
Ben Busby
Viruses represent important test cases for data federation due to their genome size and the rapid increase in sequence data in publicly available databases. However, some consequences of previously decentralized (unfederated) data are lack of consensus or comparisons between feature annotations. Unifying or displaying alternative annotations should be a priority both for communities with robust entry representation and for nascent communities with burgeoning data sources. To this end, during this three-day continuation of the Virus Hunting Toolkit codeathon series (VHT-2), a new integrated and federated viral index was elaborated. This Federated Index of Viral Experiments (FIVE) integrates pre-existing and novel functional and taxonomy annotations and virus–host pairings. Variability in the context of viral genomic diversity is often overlooked in virus databases. As a proof-of-concept, FIVE was the first attempt to include viral genome variation for HIV, the most well-studied human pathogen, through viral genome diversity graphs. As per the publication of this manuscript, FIVE is the first implementation of a virus-specific federated index of such scope. FIVE is coded in BigQuery for optimal access of large quantities of data and is publicly accessible. Many projects of database or index federation fail to provide easier alternatives to access or query information. To this end, a Python API query system was developed to enhance the accessibility of FIVE.

7 October 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
CJConor Jenkins
Conor Jenkins
ANAlexis Norris
Alexis Norris
MOMaura O’neill
Maura O’neill
SDSudipto Das
Sudipto Das
TAThorkell Andresson
Thorkell Andresson
BOBen Orsburn
Ben Orsburn
Isobaric labeling-based relative quantification techniques such as iTRAQ and TMT were introduced 15 years ago and are now nearly ubiquitous in shotgun proteomics labs around the world. The methods for data processing in these experiments has changed little since inception, with peptide database searching of all MS/MS spectra occurring concurrent or asynchronous to the quantification of the reporter fragment regions. In this study we present an alternative method for data processing whereby the reporter ion region of all MS/MS spectra are first examined and spectra that are not quantitatively interesting to the end user are discarded. The remaining MS/MS spectra that are retained can then be more rapidly searched for computationally expensive database alterations such as post-translational modifications and single amino acid variations in more practical time. We have termed this method Reporter Ion Data Analysis Reduction (RIDAR). To demonstrate the application of RIDAR, we reprocess a recent CPTAC 2 study containing approximately 7.8 million MS/MS spectra. Post RIDAR processing we can search this public dataset versus a human canonical FASTA database and a compiled proteogenomic database of over 875,000 known cancer mutations in a single day on a standard desktop computer, a time reduction of 85% compared to the conventional workflow. With the rapidly increasing size and density of shotgun proteomics data files, RIDAR facilitates rapid analysis of large proteomics datasets for researchers without access to high performance computational resources. Abstract Graphic: